This study demonstrated that -LA supplementation (300 mg/d, twice a day) for 3 months significantly decreased the serum levels of MDA and C-reactive protein (CRP), as two inflammatory and oxidative stress markers, and mood disorders in patients with episodic migraine
The bacterial growth in the vial is prevented by the preservative
Landmark trials, including CREDENCE, DAPA-CKD, EMPA-KIDNEY, and FLOW, have demonstrated their efficacy in preserving kidney function and reducing adverse outcomes
EU manufactured no import delays, no customs risk
In research published in the journal Dementia and Neurocognitive Disorders, older patients (age 55 to 80 years), with a confirmed diagnosis of dementia or memory deficit due to cerebrovascular disease, received treatment with ALC 1500 mg for 28 days
January is a seasonal period when consumer research into metabolic wellness products often increases, including searches referencing GLP-1 terminology